Table 3

Factors associated with 30-day PE-related mortality in 591 normotensive patients with acute symptomatic PE

Risk factorUnadjusted OR (95% CI)p ValueAdjusted OR (95% CI)p Value
Age >65 years2.33 (0.89 to 6.10)0.08
Male gender0.70 (0.35 to 1.41)0.32
COPD1.31 (0.44 to 3.85)0.63
CHF0.93 (0.27 to 3.14)0.91
Cardiac troponin I >0.1 ng/ml2.66 (1.36. to 5.20)0.0042.66 (1.36 to 5.20)0.004
RVD (echocardiogram)2.57 (1.28 to 5.16)0.0082.57 (1.28 to 5.16)0.008
Presence of DVT (CCUS)2.48 (1.26 to 4.88)0.0092.20 (1.10 to 4.38)§0.02
Pulse ≥110 beats/min1.92 (0.95 to 3.88)0.07
Arterial oxyhaemoglobin saturation <90%1.99 (1.02 to 3.88)0.04
Systolic blood pressure <120 mm Hg1.64 (0.83 to 3.21)0.15
Dyspnoea1.05 (0.48 to 2.28)0.90
Chest pain0.75 (0.38 to 1.47)0.40
Syncope0.85 (0.34 to 2.08)0.72
Cancer*3.12 (1.53 to 6.37)0.002
Immobilisation2.21 (1.16 to 4.21)0.02
Recent surgery0.54 (0.13 to 2.32)0.41
History of VTE1.03 (0.35 to 3.01)0.95
Thrombolysis0.99 (0.13 to 7.73)0.99
  • * Active or under treatment in the past year.

  • Immobilised patients are defined in this analysis as non-surgical patients who had been immobilised (ie, total bed rest with bathroom privileges) for 4 days or more in the month before pulmonary embolism (PE) diagnosis.

  • No variables showed evidence of confounding.

  • § Adjusted by cancer.

  • CCUS, lower extremity complete compression ultrasound; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; DVT, deep vein thrombosis; RVD, right ventricular dysfunction; VTE, venous thromboembolism.